Outcome | Instrument* | Significant* | Non-significant* | Study |
---|---|---|---|---|
Psychosocial–coordinative support | ||||
Anxiety | HADS (≥8) | X | [111] | |
HADS | X | |||
Depression | HADS (≥8) | X | [111] | |
HADS | X | |||
(Health-related) Quality of life | LLFDI-K | X | X | |
SF 8, K − 14 F-SozU | X | |||
Use of services | Counting | X | [111] | |
Counting | X | |||
Further outcomes | CCSC | X | [111] | |
SCNS | X | [111] | ||
S-JS, MOS-SS | X | |||
Physical–cognitive activation | ||||
Anxiety | FES-I | X | ||
(Health-related) Quality of life | WHOQOL-BREF | X | ||
WHOQOL-OLD | X | X | ||
SF − 20 | X | X | [117] | |
ADL-Scale | X | [119] | ||
GAS | – | – | [118] | |
Physical functioning | PASE, SPPB | X | ||
SHARE-FI, NMA®-LF | X | |||
ABC-Scale | X | [119] | ||
SFTM | X | X | [119] | |
BBS | X | [119] | ||
GAS | – | – | [118] | |
Assistance with medication intake | ||||
Use of services | Counting | X | [121] | |
Further outcomes | Counting | X | X | [121] |
KAB-MS | X | X | [120] |